Yong Yu, VP, Clinical Trial Operations at GENELUX Corp (GNLX), sold 6,530 shares at $23.73 ($155K) on 2023-08-18, disclosed to the SEC on 2023-08-22.
Open-market sale of $155k GNLX by VP, Clinical Trial Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.73 | 3,265 | $77K | 50.0% |
| 2 | $23.73 | 3,265 | $77K | 50.0% |
| Total | $23.73 avg | 6,530 | $155K | 100% |
| Filing → |
| GNLX | SELL | 2026-05-12 | $2K | — | Filing → |
| GNLX | SELL | 2026-03-26 | $2K | — | Filing → |
| GNLX | SELL | 2025-12-11 | $16K | — | Filing → |